Outlook Therapeutics, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:OTLK) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 28.82 M17.01 M19.08 M22.39 M18.58 M18.24 M21.89 M Total liabilities 101.9 M67.3 M51.54 M59.58 M50.77 M56.79 M50.89 M Total equity -73.08 M-50.29 M-32.46 M-37.19 M-32.19 M-38.55 M-28.99 M Total liabilities & shareholders' equities 28.82 M17.01 M19.08 M22.39 M18.58 M18.24 M21.89 M Total debt ——33.05 M34.44 M——26.97 M Net debt ——25.49 M25.54 M——19.22 M

News

Outlook Therapeutics: Potential Catalysts Offering An Arbitrage Opportunity (NASDAQ:OTLK)

Oncobiologics, Inc. (OTLK) Reports Q2 Loss, Lags Revenue Estimates

Outlook Therapeutics Files FDA Resolution Request After Rejection For Vision Loss Drug - Outlook Therapeu

Outlook Therapeutics secures $18.4M note, extends debt maturity

Outlook Therapeutics discusses FDA meeting on bevacizumab drug

Oncobiologics, Inc. (OTLK) Reports Q1 Loss, Misses Revenue Estimates

OTLK Stock Crashes 67% in a Week: Here's What You Need to Know

Outlook Therapeutics stock price target lowered to $0.50 at H.C. Wainwright

Dow Jumps Over 300 Points On First Trading Day Of 2026: Fear & Greed Index Remains In 'Neutral Zone - Micron Technology (NASDAQ:MU), NVIDIA (NASDAQ:NVDA)

The Narrowing Pathway for Biotech Securities Fraud Claims: Lessons from Outlook Therapeutics - TipRanks.com

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.66%

Why Intelligent Bio Solutions Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Aimei Health Technology (NASDAQ:AFJK), Astera Labs (NASDAQ:ALAB)